LB Pharmaceuticals investigational product

· LB Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LB Pharmaceuticals investigational product, covering 2026-04-09 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: 52-week Open Label Safety-Tolerability Study [Phase 3]